The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Germentin 125 mg/31.25 mg per 5 ml Powder for Oral Suspension

125 mg/31.25 mg/5ml Powder for oral suspension

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/034/002

Main Information

Trade NameGermentin 125 mg/31.25 mg per 5 ml Powder for Oral Suspension
Active SubstancesClavulanic acid
Strength125 mg/31.25 mg/5ml
Dosage FormPowder for oral suspension
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/034/002

Group Information

ATC CodeJ01CR Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR02 amoxicillin and enzyme inhibitor


Licence Issued05/03/2004
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0037-071-034
Interchangeable List DocumentPDF of Interchangeable List
« Back